Target intelligence / Profile preview

Complement component 4B (C4B)

Target
C4B
Molecular classification
Complement system protein, Opsonin, Other (precursor fragment from complement cascade)
01

Overview

Complement component 4B (C4B) is a central protein of the classical and lectin complement pathways, encoded by the C4B gene. Upon activation, the C4 protein is cleaved to produce the fragment C4b, which covalently attaches to pathogen and altered self-cells. C4b acts as an opsonin, enabling marked cells to be cleared by immune cells, and provides a scaffold for the formation of the C3 and C5 convertases that mediate further complement activation. Deficiency in C4B is associated with a predisposition to autoimmune diseases (notably systemic lupus erythematosus), while abnormal activity or regulation can contribute to inflammatory conditions. C4b is not an enzyme or receptor but is a functional protein fragment critical for opsonization and immune complex clearance.

Other names
C4bChido blood groupComplement component 4BC4B
02

Mechanism of action

Acts as an opsonin, marking pathogens and altered self-cells for phagocytosis. Platform for assembly of C3 and C5 convertases, enabling downstream complement activation.

03

Biological functions

Immune responseOpsonizationActivation of complement pathway (classical and lectin)Formation of C3 and C5 convertases
04

Disease associations

Autoimmune disease (e.g., lupus erythematosus)InfectionInflammation
05

Safety considerations

Overactivity can contribute to tissue inflammation/damagedeficiency associated with increased infection and autoimmunity
06

Biomarkers

Deficiency may serve as a biomarker for autoimmune diseases such as lupus erythematosus

Beyond the preview

Go deeper on Complement component 4B (C4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement component 4B (C4B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call